Skip to main content
IntegraGen logo

IntegraGen — Investor Relations & Filings

Ticker · ALINT ISIN · FR0010908723 LEI · 969500CQD8K0BUIGDH55 PA Professional, scientific and technical activities
Open in API
Filings indexed 162 across all filing types
Latest filing 2022-07-13 Earnings Release
Country FR France
Listing PA ALINT

About IntegraGen

https://integragen.com/

IntegraGen, an OncoDNA company, specializes in translating molecular research into clinical practice, with a primary focus on cancer genomics and rare genetic diseases. The company provides comprehensive genomic services, including Next-Generation Sequencing (NGS) and advanced bioinformatics analysis, to academic researchers, biopharmaceutical companies, and clinical research organizations. Operating from a CLIA/CAP-certified laboratory, IntegraGen is a key genomics partner for oncology clinical trials. Its core mission involves identifying novel genetic biomarkers to develop and commercialize molecular diagnostic tests, delivering interpretable genomic data to advance both research and patient care.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Autres communiqués
Earnings Release Classification · 100% confidence The document is explicitly titled "COMMUNIQUE DE PRESSE - DIFFUSION IMMEDIATE" (Press Release - Immediate Release) and announces the "Chiffre d'affaires de 6,4 M€ au premier semestre 2022" (Revenue of €6.4M for the first half of 2022). This content focuses on the key financial highlights for a specific reporting period (H1 2022) but is presented as a brief announcement, not the comprehensive report itself. The text also mentions that the full financial results will be published later ("Les résultats financiers du premier semestre 2022 seront publiés le 18 octobre 2022"). This structure strongly indicates an Earnings Release (ER), which provides initial highlights before the full Interim Report (IR) is released. The document length (5143 chars) is substantial for a simple RPA, but the content is purely results highlights, fitting the ER definition. H1 2022
2022-07-13 French
Rapports financiers et d'audit annuels / Rapport financier annuel
Audit Report / Information Classification · 98% confidence The document is titled 'Comptes annuels' (Annual Accounts) and contains a detailed 'Sommaire' (Table of Contents) listing sections like 'Rapport de l'expert comptable' (Accountant's Report), 'Bilan actif' (Balance Sheet Asset), 'Bilan passif' (Balance Sheet Liability), and 'Compte de résultat' (Income Statement). It explicitly covers the period '01/01/2021 au 31/12/2021' (Fiscal Year End 2021). The presence of the full balance sheet and income statement details, along with the accountant's report, strongly indicates this is a comprehensive annual financial filing. Although the text is in French, the structure aligns perfectly with a full Annual Report (10-K equivalent for French reporting standards). Since it contains the full financial statements and is not merely an announcement of publication, it should be classified as the Annual Report itself, which corresponds to the '10-K' code in our system for comprehensive yearly reports. FY 2021
2022-04-29 French
Informations privilégiées / Communiqué sur comptes, résultats
Earnings Release Classification · 95% confidence The document is a press release titled 'Résultats annuels 2021' (Annual Results 2021) issued by IntegraGen. It provides a summary of financial performance, including key highlights like revenue growth, EBITDA, and net income, along with management commentary and balance sheet tables. While it contains financial data, it is structured as an initial announcement of results (Earnings Release) rather than a full statutory Annual Report (10-K). It fits the definition of an Earnings Release (ER) as it provides key highlights of the period's financial results. FY 2021
2022-04-29 French
Inside Information / News release on accounts, results
Earnings Release Classification · 99% confidence The document is explicitly titled as a 'PRESS RELEASE – FOR IMMEDIATE DISTRIBUTION' announcing 'IntegraGen reports 2021 annual results'. It contains detailed financial tables for the year ending December 31, 2021, including Revenues, EBITDA, EBIT, and Net Result, along with balance sheet data. The text discusses operational performance for the full fiscal year and provides an outlook for 2022. This content structure is characteristic of an Earnings Release (ER), which provides the initial announcement of periodical financial results, often released before the full 10-K filing. Since it is a press release summarizing the annual results, 'ER' is the most appropriate classification over '10-K' (which is the formal regulatory filing) or 'IR' (which is typically for interim/quarterly reports). The document length (10,116 chars) is substantial enough to be the release itself, not just a brief announcement of a report (RPA/RNS). FY 2021
2022-04-29 English
Acquisition ou cession des actions de l'émetteur / Information relative au contrat de liquidité
Regulatory Filings Classification · 99% confidence The document is titled "BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE" (Semi-annual Liquidity Contract Balance Sheet) and reports on the status of a liquidity contract (market making agreement) for IntegraGen S.A. as of December 31, 2021, covering transactions from July 1, 2021, to December 31, 2021. This type of report details the activity under a specific financial arrangement, often related to share trading or market stabilization. It is not a standard comprehensive financial report (10-K or IR), an earnings release (ER), or a management discussion (MDA). It is a specific regulatory or contractual disclosure related to market operations. Given the options, this document details specific financial/market activities related to share transactions under a contract, which is closest in nature to a specialized financial disclosure. Since there is no specific code for 'Liquidity Contract Report,' and it details transactions and balances, it falls under the general category of specialized financial reporting or regulatory disclosure. However, it is a detailed report, not just an announcement of a report. The closest fit among the provided codes for a specific, non-standard financial/market disclosure that isn't a full annual/interim report is often the general 'Regulatory Filings' (RNS) or potentially 'Capital/Financing Update' (CAP) if the liquidity contract is viewed as a financing tool, but RNS is the safest fallback for specific, non-core reports. Upon review, this document is a mandatory periodic report detailing the execution of a liquidity agreement, which is a specific regulatory requirement in many jurisdictions for listed companies. Since it is a detailed report itself (not an announcement of a report) and doesn't fit 10-K, IR, ER, or DIV, RNS (Regulatory Filings) serves as the most appropriate general category for specific, non-standard regulatory disclosures.
2022-01-18 French
Informations privilégiées / Information sur chiffre d’affaires annuel
Earnings Release Classification · 100% confidence The document is explicitly titled 'COMMUNIQUE DE PRESSE - DIFFUSION IMMEDIATE' (Press Release - Immediate Release) and announces the 'Chiffre d'affaires 2021' (2021 Revenue) figures. It provides key highlights (revenue growth, cash position) but explicitly states that the full financial results for 2021 will be published later ('Les résultats financiers pour l'année 2021 seront publiés le 24 avril 2022'). This structure—a brief, immediate announcement of preliminary or key results—fits the definition of an Earnings Release (ER). It is not the full Annual Report (10-K) or the comprehensive Interim Report (IR). The document length (4915 chars) is consistent with a press release rather than a full statutory filing. FY 2021
2022-01-14 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.